Historical record - last NADAC effective date: 7/20/2022
This NDC is on FDA's drug shortage list (posted Jan 19, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3447 per EA under NDC 65862016390. Its NADAC has been published 503 times since Nov 28, 2013.
FDA first approved this application on Aug 24, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 20 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862016390
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/20/2022
Active Ingredients
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078450FDA Approved
8/24/2007
TE Code
AB
On Market Since
8/24/2007
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has been published 503 times since Nov 28, 2013, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3447 per EA |
|---|---|
| All-time high | $0.7170 (Aug 12, 2015) |
| All-time low | $0.3131 (Mar 23, 2022) |
| Median price | $0.4761 |
| Average price | $0.4884 |
| Largest weekly change | +37.0% (Apr 20, 2022) |
| Weeks tracked | 503 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-16.0%
All
-33.1%
Last surveyed Jul 12, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.3447 per EA (NDC 65862016390), effective Jul 12, 2023.
How has the price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB changed over time?
Over the history we have for it, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has declined 33.1%. It has been tracked across 503 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
Since Nov 28, 2013, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has ranged from a low of $0.3131 (Mar 23, 2022) to a high of $0.7170 (Aug 12, 2015), with a median of $0.4761 per EA.
Are there cheaper alternatives to QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB (NDC 65862016390) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Is QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB in shortage?
Yes — NDC 65862016390 is currently listed in FDA's drug shortage database (posted Jan 19, 2023). Reported reason: Discontinuation of the manufacture of the drug.